Zhejiang Medicine (China) Today
Zhejiang Medicine is trading at 15.40 as of the 7th of February 2025, a 2.53 percent increase since the beginning of the trading day. The stock's open price was 15.02. The performance scores are derived for the period starting the 8th of January 2025 and ending today, the 7th of February 2025. Click here to learn more.
Valuation
Check how we calculate scores
Zhejiang Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Zhejiang Medicine's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Zhejiang Medicine or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President Chairman | Chun Lu |
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Zhejiang Medicine Co (600216) is traded on Shanghai Stock Exchange in China and employs 6,227 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 14.71 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zhejiang Medicine's market, we take the total number of its shares issued and multiply it by Zhejiang Medicine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Zhejiang Medicine operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 961.64 M outstanding shares.
Zhejiang Medicine generates positive cash flow from operations, but has no cash available
Check Zhejiang Medicine Probability Of Bankruptcy
Zhejiang Stock Against Markets
Zhejiang Medicine Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zhejiang Medicine stock to make a market-neutral strategy. Peer analysis of Zhejiang Medicine could also be used in its relative valuation, which is a method of valuing Zhejiang Medicine by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Zhejiang Medicine Corporate Management
Elected by the shareholders, the Zhejiang Medicine's board of directors comprises two types of representatives: Zhejiang Medicine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zhejiang. The board's role is to monitor Zhejiang Medicine's management team and ensure that shareholders' interests are well served. Zhejiang Medicine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zhejiang Medicine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Wei Ye | Secretary Board | Profile | |
| Jun Zhao | Chief Scientist | Profile | |
| Huan Yu | Senior Manager | Profile | |
| Guangshan Guo | Accounting Supervisor | Profile |
Other Information on Investing in Zhejiang Stock
Zhejiang Medicine financial ratios help investors to determine whether Zhejiang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhejiang with respect to the benefits of owning Zhejiang Medicine security.